Acutaas Chemicals Q4 FY26: PAT Surges 114%, Revenue at ₹4,328 Mn

3 min read     Updated on 02 May 2026, 06:15 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Acutaas Chemicals delivered outstanding Q4 FY26 performance with net profit jumping 114.1% to ₹1,343 million and revenue reaching ₹4,328 million, up 40.3% year-on-year. The company's EBITDA margin expanded significantly to 42.4% from 27.5%, while full-year FY26 revenue grew 33.0% to ₹13,394 million with PAT increasing 122.2% to ₹3,564 million. The Board recommended a final dividend of ₹2.5 per share and published the audited results in Financial Express newspapers on May 1, 2026, ensuring regulatory compliance.

powered bylight_fuzz_icon
38819995

*this image is generated using AI for illustrative purposes only.

Acutaas Chemicals Limited announced robust financial results for the quarter ended March 31, 2026, demonstrating significant growth across key performance metrics. The company reported Q4 net profit of ₹1,343 million compared to ₹627 million in the same period last year, while revenue reached ₹4,328 million versus ₹3,085 million year-on-year, marking substantial growth in both profitability and top-line performance.

Strong Financial Performance in Q4

The company delivered exceptional financial results with profit after tax (PAT) reaching ₹1,343 million, representing a remarkable 114.1% growth compared to the previous year's ₹627 million. The revenue performance was equally impressive, with Q4 revenue of ₹4,328 million showing strong year-on-year growth from ₹3,085 million in the corresponding quarter of the previous year.

Key Financial Metrics: Q4 Current Year Q4 Previous Year Growth
Net Profit: ₹1,343 million ₹627 million 114.1% increase
Revenue: ₹4,328 million ₹3,085 million 40.3% growth
EBITDA: ₹1,835 million ₹850 million 116.0% increase
EBITDA Margin: 42.4% 27.5% 1490 bps expansion

EBITDA Performance and Margin Expansion

The company's operational efficiency showed remarkable improvement with EBITDA reaching ₹1,835 million compared to ₹850 million in the previous year. More notably, the EBITDA margin expanded significantly to 42.4% from 27.5% year-on-year, indicating strong cost management and operational leverage. This substantial margin expansion demonstrates the company's ability to optimize its operations while scaling revenue growth.

FY26 Full Year Performance

For the full fiscal year FY26, the company reported total revenue of ₹13,394 million, up 33.0% from ₹10,069 million in FY25. PAT for FY26 reached ₹3,564 million, a 122.2% increase from ₹1,604 million in the previous year. EBITDA for the year stood at ₹4,804 million with an EBITDA margin of 35.9%, compared to ₹2,321 million and 23.0% respectively in FY25.

FY26 Financial Metrics: FY26 FY25 Growth
Revenue: ₹13,394 million ₹10,069 million 33.0%
PAT: ₹3,564 million ₹1,604 million 122.2%
EBITDA: ₹4,804 million ₹2,321 million 107.0%
PAT Margin: 26.6% 15.9% 1070 bps

Official Board Meeting and Dividend Declaration

In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors at their meeting held on April 30, 2026, recommended a final dividend of ₹2.5 per equity share at the rate of 50% on the face value of ₹5 per share. The dividend is subject to deduction of tax, if any, and requires confirmation by shareholders in the ensuing 19th Annual General Meeting. Company Secretary CS Ekta Kumari Srivastava provided the official intimation to both BSE and NSE exchanges.

Regulatory Details: Information
Meeting Date: April 30, 2026
Regulation: SEBI Regulation 30
Total Equity Shares: 8,18,71,122
Share Face Value: ₹5 each
Dividend Rate: 50%
Final Dividend: ₹2.5 per equity share

Regulatory Compliance and Newspaper Publication

Following the board meeting outcomes, Acutaas Chemicals published its audited financial results for Q4 and FY26 in newspapers on May 1, 2026, in compliance with Regulation 30 & 47 of SEBI regulations. The results were published in Financial Express All India editions (English) and Financial Express Ahmedabad edition (Gujarati) newspapers, ensuring proper disclosure to stakeholders. Company Secretary CS Ekta Kumari Srivastava confirmed the newspaper publication through official intimation to BSE and NSE exchanges.

Auditor Appointments and Material Subsidiary

The Board appointed M/s Chirag Vallabhhai Vekariya & Co., a Cost and Management Accountants firm (Firm Registration No. 001422), as the Cost Auditors for FY 2026-27. Additionally, M/s K. C Mehta & Co. LLP., a Chartered Accountants firm (Firm Registration No. 106237W), was appointed as the Internal Auditors for FY 2026-27. In accordance with the Company's "Policy for Determination of Material Subsidiaries," Indichem INC has been identified as a Material Subsidiary based on the latest audited consolidated financial statements.

Management Outlook

Executive Chairman and Managing Director Mr. Naresh Patel expressed confidence in delivering 25% revenue growth in FY27. The company's strategy focuses on building a diversified chemicals business across three high-growth verticals - Battery Chemicals, Semiconductors, and Pharmaceutical CDMO. The record date, book closure dates, and dividend pay-out date for the final dividend shall be intimated in due course of time.

Historical Stock Returns for Acutaas Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.80%+8.42%+26.71%+70.10%+154.77%+549.16%

Can Acutaas Chemicals sustain its exceptional 42.4% EBITDA margins in FY27 amid potential raw material cost pressures and competitive dynamics?

How will the company's expansion into battery chemicals and semiconductors position it to capitalize on India's growing electric vehicle and electronics manufacturing sectors?

What specific strategies will Acutaas employ to achieve the ambitious 25% revenue growth target for FY27 given the high base effect from FY26's strong performance?

ACUTAAS CHEMICALS LIMITED Launches Second Saksham Niveshak Campaign for KYC Updates and Unclaimed Dividends

2 min read     Updated on 14 Apr 2026, 09:16 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

ACUTAAS CHEMICALS LIMITED has initiated the second 100-day Saksham Niveshak campaign from April 01, 2026 to July 09, 2026, following IEPFA and MCA directives dated March 27, 2026. The campaign focuses on helping shareholders claim unclaimed dividends and update KYC details including PAN linked with Aadhaar, contact information, and bank account details. Shareholders are advised to contact Registrar and Transfer Agent MUFG Intime India Private Limited for assistance, as dividends unclaimed for seven consecutive years are liable to be transferred to IEPF.

powered bylight_fuzz_icon
37727165

*this image is generated using AI for illustrative purposes only.

ACUTAAS CHEMICALS LIMITED has launched its second 100-day "Saksham Niveshak" campaign, running from April 01, 2026 to July 09, 2026, as part of a nationwide initiative to help shareholders claim unclaimed dividends and update their KYC details. The campaign follows communication from the Investor Education and Protection Fund Authority (IEPFA) and Ministry of Corporate Affairs (MCA) dated March 27, 2026.

Campaign Objectives and Timeline

The second phase of the Saksham Niveshak initiative focuses on shareholders whose dividends remain unclaimed, with particular emphasis on KYC updation and related compliance measures. The campaign aims to facilitate shareholders in two primary areas:

Objective: Details
Dividend Claims: Claim unpaid/unclaimed dividends for any financial year to prevent transfer to IEPFA
KYC Updates: Update PAN (linked with Aadhaar), contact details, bank account information, and nomination details
Campaign Duration: April 01, 2026 to July 09, 2026
Publication Date: April 14, 2026 in Financial Express (English and Gujarati editions)

Shareholder Support and Contact Information

Since dividends on shares are payable only through electronic mode, unclaimed or unpaid dividend amounts will be credited to shareholders' bank accounts only after required information and documents are updated. Shareholders with incomplete KYC records or unclaimed dividends are requested to contact the company's Registrar and Transfer Agent at the earliest.

Registrar and Transfer Agent Details:

Regulatory Compliance and Advisory

The company has emphasized the importance of prompt action during the campaign period. As per applicable provisions of the Companies Act, 2013 and related rules, dividends remaining unclaimed for seven consecutive years, along with corresponding base shares (if available), are liable to be transferred to the Investor Education and Protection Fund Authority (IEPF).

The campaign represents a proactive approach to ensure shareholders can safeguard their entitlements and maintain compliance with statutory requirements. The company has published the notice in accordance with Regulation 30 and 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

Documentation and Process

The newspaper publication was released on Tuesday, April 14, 2026, in Financial Express All India editions (English) and Financial Express Ahmedabad edition (Gujarati). The notice was signed by CS Ekta Kumari Srivastava, Company Secretary and Compliance Officer, and submitted to both BSE Limited (Scrip Code: 543349) and National Stock Exchange of India Limited (NSE Symbol: ACUTAAS) for record and dissemination.

Historical Stock Returns for Acutaas Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+3.80%+8.42%+26.71%+70.10%+154.77%+549.16%

How might the success rate of this second campaign compare to the first phase, and what improvements has Acutaas Chemicals implemented based on previous learnings?

What potential impact could widespread unclaimed dividend transfers to IEPF have on Acutaas Chemicals' financial statements and shareholder equity structure?

Will other listed companies likely follow similar proactive campaigns, and could this become a new industry standard for investor relations?

More News on Acutaas Chemicals

1 Year Returns:+154.77%